SCHEMBL1897161

SCHEMBL1897161

COC(=O)CCCCCCCC(C(=O)OC)C1CC(C)(C)N(C)C(C)(C)C1

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.39
PABPC1 P11940 1/20 0.38
APOBEC3A P31941 1/20 0.38
APOBEC3G Q9HC16 1/20 0.38
EPHX2 P34913 6/20 0.37
TSHR P16473 2/20 0.35
LMNA P02545 2/20 0.34
ALDH1A1 P00352 2/20 0.34
KMT2A Q03164 1/20 0.33
PTGER2 P43116 2/20 0.32
PTGER4 P35408 1/20 0.32
PTGER3 P43115 1/20 0.32
EPHX1 P07099 1/20 0.32
KAT2B Q92831 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28264667 0.90 L3MBTL1 (0.42) L3MBTL1PABPC1APOBEC3AAPOBEC3GEPHX2
SCHEMBL1562364 0.90 FFAR4 (0.37) EPHX2TSHRALDH1A1PTGER2PTGER4
SCHEMBL3149950 0.81 TSHR (0.47) L3MBTL1EPHX2TSHRLMNAALDH1A1
SCHEMBL742992 0.80 L3MBTL1 (0.38) L3MBTL1PABPC1APOBEC3AAPOBEC3GEPHX2
SCHEMBL26698391 0.80 L3MBTL1 (0.38) L3MBTL1PABPC1APOBEC3AAPOBEC3GEPHX2
SCHEMBL207971 0.80 FFAR4 (0.35) TSHRLMNAALDH1A1PTGER2PTGER4
Sebacic Acid SCHEMBL28259015 0.78 TSHR (0.41) L3MBTL1PABPC1APOBEC3AAPOBEC3GEPHX2
SCHEMBL223756 0.76 NAAA (0.44) L3MBTL1EPHX2TSHRLMNAALDH1A1
SCHEMBL17985334 0.76 NAAA (0.44) L3MBTL1EPHX2TSHRLMNAALDH1A1
SCHEMBL1019749 0.76 FFAR4 (0.41) TSHRLMNAALDH1A1PTGER2PTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049606-B1 WHITE MIXTURE FOR APPLYING A COATING LITOKOL S P A (IT) 2018-12-26 EP claimed
EP-4267659-B1 SILOXANE-IMIDE COPOLYMER AND ADDITION CURABLE COMPOSITION COMPRISING SAME MOMENTIVE PERFORMANCE MAT INC (US) 2026-03-25 EP disclosed
US-12492273-B2 Compound, resin precursor, cured object, optical element, optical system, interchangeable camera lens, optical device, cemented lens, and method for manufacturing cemented lens NIKON CORPORATION (JP) 2025-12-09 US disclosed
US-20250361378-A1 CURABLE COMPOSITION FOR SEALING MATERIAL, AND PANEL STRUCTURE USING SAID CURABLE COMPOSITION SEKISUI FULLER COMPANY, LTD. (JP) 2025-11-27 US disclosed
EP-3458520-B1 CURABLE, DUAL CURE, ONE PART SILICONE COMPOSITION MOMENTIVE PERFORMANCE MAT INC (US) 2025-11-05 EP disclosed
EP-3431520-B1 PROCESS FOR PRODUCING OXYMETHYLENE COPOLYMER MITSUBISHI GAS CHEMICAL CO (JP) 2025-09-24 EP disclosed
US-20250206884-A1 ULTRAVIOLET RADIATION-CURABLE POLYSILOXANE COMPOSITION, AND DAMPING MATERIAL TAICA CORPORATION (JP) 2025-06-26 US disclosed
EP-4541829-A1 CURABLE COMPOSITION FOR SEALING MATERIAL, AND PANEL STRUCTURE USING SAID CURABLE COMPOSITION Sekisui Fuller Company, Ltd. (JP) 2025-04-23 EP disclosed
US-12248119-B2 Compound, resin precursor, cured object, optical element, optical system, interchangeable camera lens, optical device, cemented lens, and method for manufacturing cemented lens NIKON CORPORATION (JP) 2025-03-11 US disclosed
WO-2024262386-A1 CATHETER テルモ株式会社 2024-12-26 WO disclosed
EP-2223950-A1 ALIPHATIC POLYESTER RESIN AND METHOD FOR PRODUCING THE SAME Mitsubishi Chemical Corporation (JP) 2010-09-01 EP disclosed
EP-1767576-B1 RESIN COMPOSITION AND USE THEREOF MITSUI CHEMICALS INC (JP) 2009-12-02 EP disclosed
US-20090118401-A1 Curable Composition CEMEDINE CO., LTD. (JP) 2009-05-07 US disclosed
US-20080304393-A1 Resin Composition And Use Thereof MITSUI CHEMICALS, INC. 2008-12-11 US disclosed
EP-1767576-A1 RESIN COMPOSITION AND USE THEREOF Mitsui Chemicals, Inc. (JP) 2007-03-28 EP disclosed
US-7135518-B2 Curable compositions, sealing material, and adhesive SEKISUI CHEMICAL CO., LTD. (JP) 2006-11-14 US disclosed
US-20050261412-A1 Curable compositions, sealing material, and adhesive SEKISUI CHEMICAL CO., LTD. (JP) 2005-11-24 US disclosed
EP-1457527-A1 CURABLE COMPOSITIONS, SEALING MATERIAL, AND ADHESIVE SEKISUI CHEMICAL CO., LTD. (JP) 2004-09-15 EP disclosed
US-20030225239-A1 Michael addition type urethane urea resin, production process therefor, adhesive, production process therefor, coating agent for forming ink receiving layer and recording material TOYO INK MANUFACTURING CO., LTD. (JP) 2003-12-04 US disclosed
EP-1146061-A1 MICHAEL ADDITION TYPE URETHANE-UREA RESIN, PROCESS FOR PRODUCING THE SAME, PRESSURE-SENSITIVE ADHESIVE, PROCESS FOR PRODUCING THE SAME, COATING MATERIAL FOR FORMING INK-RECEIVING LAYER, AND RECORDING MATERIAL Toyo Ink Manufacturing Co. Ltd. (JP) 2001-10-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12248119-B2 Compound, resin precursor, cured object, optical element, optical system, interchangeable camera lens, optical device, cemented lens, and method for manufacturing cemented lens RAD51, GFER, MLLT1 L3MBTL1 1748/4885PABPC1 4552/4885APOBEC3A 4575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.